Skip to content

Effect of acute hypervolemic fluid infusion on intraoperative tissue perfusion in patients undergoing pancreatic Robotic surgery

Effect of acute hypervolemic fluid infusion on intraoperative tissue perfusion in patients undergoing pancreatic Robotic surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800014480
Enrollment
Unknown
Registered
2018-01-16
Start date
2017-09-01
Completion date
Unknown
Last updated
2018-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic tumor

Interventions

Group A(Acute hypervolemic fluid infusion group):During the induction period (30min before and after induction),infusion is 25ml/kg, and continuous infusion of 8ml/kg/h during the operation (colloid a
Group T(Traditional group):During the induction period, the infusion is 5ml/kg, physiological demand and preoperative loss are supplemented by 4-2-1, intraoperative blood loss is infused by colloid a

Sponsors

Ruijin hospital, Shanghai
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Patients who aged 18-75y, ASA I to III, BMI18-30kg/m2, Hb>80g/L and HCT>30%, selected for the pancreatic operation , including D- segment pancreatectomy, pancreatectomy, pancreatoduodenectomy, pancreatoduodenectomy, pancreatoduodenectomy, pancreatoduodenectomy etc.

Exclusion criteria

Exclusion criteria: 1. Any cerebrovascular accident occurred in 3 months, such as stroke, transient ischemic attack (TIA) and so on; 2. Serious abnormal liver and kidney function; 3. There are severe diabetic complications (diabetic ketoacidosis, hyperosmolar coma, various infections, macroangiopathy, diabetic nephropathy, diabetic retinopathy, diabetic cardiomyopathy, diabetic neuropathy, diabetic foot); 4. Unstable angina, myocardial infarction or patients with severe arrhythmia in 3 months; 5. In severe sedation blood pressure = 160/100mmHg(WHO-ISH = 160/100 mm Hg blood pressure hypertension guidelines 2/3 hypertension); 6. Pulmonary ventilation function or diffuse function in severe disorder; 7. Severe pancreatitis; 8. There is a contraindication or anaphylaxis of narcotic drugs; 9. The accuracy of the monitoring data (aortic balloon counterpulsation, pacemaker, peripheral vascular disease); 10. Coagulation disorders and serious electrolyte disorders; 11. Patients who participated in other studies within 30 days.

Design outcomes

Primary

MeasureTime frame
Lactate;

Secondary

MeasureTime frame
1. Cycle stability :the value of each time point SBP, DBP, MAP, HR, SVV, CI, CVP, II/V1/aVL- ST. 2. Liver and kidney function before surgery within three days and the day after operation: ALT, AST, total bilirubin, creatinine, urea, Hb/Hct. 3. Postoperative complications :conjunctival edema, subcutaneous emphysema,;

Countries

China

Contacts

Public ContactYan Luo

Department of Anesthesiology, Ruijin hospital, Ruijin hospital, Shanghai

13916323078@163.com+86 13916323078

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026